InforMedix Rings Up Med-ePhone - Mobile, Wireless Patient Medication Adherence Solution

Main Category: Medical Devices
Also Included In: Compliance
Article Date: 30 Nov 2007 - 4:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

InforMedix Holdings, Inc. (OTCBB: IFMX, http://www.informedix.com), developer of the Med-eMonitor™, an interactive smart pillbox system for medication adherence and health management, is planning to introduce a new device, the Med-ePhone™.

InforMedix expects that the Med-ePhone system will provide a simple, inexpensive method for reminding users to take their medications regularly, and that the device will record and monitor patient medication adherence and health status over mobile phones and landlines. The Med-ePhone system is being designed to send patient- reported data to be analyzed by proprietary software algorithms already operational in InforMedix's Med-eXpert™ System which will then alert loved ones and/or care managers when a patient's medications are missed or health declines. Once Med-ePhone users are linked into the system, they will receive up to three daily reminders. These reminders will be kept short and simple to encourage high levels of user satisfaction, and will include prompts to provide answers to simple health status queries. Six of InforMedix's issued patents disclose the use of voice technologies to improve patient medication adherence.

In addition to tracking patient adherence to their medication use and health status, InforMedix expects that the Med-ePhone system will provide healthcare professionals with automated real-time alerts when patients miss their medications or their health declines.

"We designed Med-ePhone to be an entry-level product to complement our Med-eMonitor," said Mike Gavin, Vice President of Research and Development at InforMedix. "We anticipate that the Med-ePhone will be an excellent solution for patients and their families for managing simpler medication regimens while preserving the core features of the Med-eMonitor System's prompting, monitoring, and reporting services."

Remie Smith, Vice President of Software Development at InforMedix remarked, "What excites us about the Med-ePhone is that we will remotely program it, monitor the patients, and report the urgent alerts through our same Med-eXpert System, which has proven to be a highly reliable and robust database and reporting engine."

"We expect that the Med-ePhone will be another important device in our patient empowerment toolbox," said Bruce A. Kehr, MD, CEO of InforMedix. "InforMedix's goal is to help people lead safe, productive, and independent lives while bringing peace-of-mind to patients and their loved ones. With Med-ePhone, we plan to continue to make medication use safe and easy with an entry-level, mass-market product for patients on simpler medication regimens. The Med-ePhone is being designed to complement the Med-eMonitor's functionality, which provides a comprehensive management system for the more complex patients, including individualized alerts, instructions, and medication education and monitoring for up to twenty-five different medications per patient. After the planned launch, with two products at two price points, we believe that InforMedix will be able to provide solutions for virtually every conceivable medication adherence challenge."

Med-ePhone is currently under development and being tested. Upon successful completion of testing, InforMedix expects to introduce it to the consumer market through pharmacies in early 2008.

About InforMedix, Inc.

InforMedix, Inc., based in Rockville, Maryland, has developed the Med- eMonitor™ and Med-ePhone™ System as The Medication Adherence Solution for consumer product and disease management markets, to deliver peace- of-mind, improved independent living, and better health outcomes to patients and their loved ones. The Med-eMonitor System ("Medication, Safe and Easy"™) integrates a portable patient-interactive "smart pillbox", hardware, software, and call center monitoring. This is designed to enable chronically ill patients and their loved ones, professionals in disease management programs, and medical researchers to efficiently monitor and manage patients' medication and care plan adherence, clinical response, and drug safety.

http://www.informedix.com

Safe Harbor Statement

This press release may contain forward looking statements that involve risks and uncertainties, including statements regarding our business strategy and development plans, plans for entering into new businesses, the anticipated introduction of new products, anticipated sources and uses of funds and other statements regarding our plans, objectives, expectations and intentions that are not historical facts. Because these forward-looking statements involve risks and uncertainties, actual results could differ materially from those discussed in this press release. These risks and uncertainties are described in greater detail in the reports that we file with the Securities and Exchange Commission. Our actual results, performance or achievements may vary materially from those expressed or implied in any forward-looking statements. All forward-looking statements reflect our beliefs and expectations as of the date of this press release and should not be relied upon as representing our views as of any subsequent date. While we may elect to update these forward- looking statements publicly at some point in the future, we specifically disclaim any obligation to do so, whether as a result of new information, future events or otherwise.

InforMedix, Inc.